Last updated: 2026-09-16 12:10:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Anebulo Pharmaceuticals, Inc. (ANEB) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,00, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,00 to $2,85. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
$9,33 | |
$0,00 | |
$0,39 | |
-- | |
1,19K | |
-- | |
$2,85 | |
$0,00 | |
-- | |
-- |
Anebulo Pharmaceuticals, Inc. (ANEB) is trading at $-- in pre-market trading as of --, -- from the previous close of $0,39
Pre-market trading shows how investors are pricing ANEB before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Anebulo Pharmaceuticals, Inc. (ANEB) moved from $0,36 to $0,39, representing a gain of 8,87% ($0,03).
The stock traded between $0,01 and $0,39 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 114,29 shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0,0%
ANEB is currently trading at $0,00, placing it 0,0% of the way from its 52-week low of $0,00 to its 52-week high of $2,85. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ANEBULO PHARMAC INC
| Exchange | NASDAQ |
Eligible investors can buy real shares of Anebulo Pharmaceuticals, Inc. (ANEB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.